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Oliver Reiser opened the discussion of the paper by Peter Dobson: Is a size of
below 20 nm critical to achieve cell penetration by nanoparticles?
Peter Dobson responded: No, I chose this as a typical size. I believe that the
most important point is the surface chemistry and that particle size could be a
secondary factor. On the other hand, smaller particles of <20 nm will induce a
distortion of the outer cell membrane enabling the particle to penetrate by
endocytosis, but this requires a strong aﬃnity brought about by the nanoparticle–
cell surface interaction.
Ivan Parkin remarked: The antimicrobial properties of nanodiamond may
have been misrepresented in the literature as the commercial solutions contain a
variety of antimicrobial agents. Studies must make sure that these are not present
if antimicrobial analyses are to be performed.
Peter Dobson replied: I fully agree, but on the other hand nanodiamond has
got unique energy levels with respect to water and related systems.1
1 C. E. Nebel, Nature Materials, 2013, 12, 780.
Dejian Zhou remarked: What is your favourite inorganic drug nanocarrier
and why?
Peter Dobson responded: I think this has to be porous nanoparticles of silica.
They are relatively easy to make and to load. The problems come in allowing them
to circulate and target the right cells and then release their payload. I select this
choice also because there do not appear to be any adverse reactions to small
quantities of silica in the body. Silica is also close to ideal for the functionalisation
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss.
Faraday Discussions
Cite this: DOI: 10.1039/C4FD90078B
DISCUSSIONS
Pu
bl
ish
ed
 o
n 
15
 Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
on
 0
3/
02
/2
01
5 
21
:0
2:
52
. 
View Article Online
View Journal
protocols that will need to be adopted. So, to summarise: porous silica is my
favourite, but I am less sure about rendering them with the right functionality for
circulation, attachment and drug release.
Dejian Zhou commented: How do you achieve controlled release of drugs from
mesoporous silica nanoparticles to only release the drug load when it reaches
the target, without release occurring during drug transport? We have recently
developed a pH-responsive DNA-based drug carrier that displays reversible
pH-triggered conformational changes between a four-stranded I-motif and single-
stranded structure.1 Do you think that this DNA system could be used for
controlled release of mesoporous silica nanoparticles?
1 L. Song, V. H. B. Ho, C. Chen, Z. Yang, D. Liu, R. Chen and D. Zhou, Adv. Healthcare Mater.,
2013, 2, 275–280.
Peter Dobson answered: I have little to add because triggering release is not
going to be easy. If the proposed pH-triggered method works under physiological
pH conditions then it is worth a try. My rst understanding of the work published
by Song et al. is that a large pH swing from 7.6 to 5.1 is needed.1 I am not sure, but
believe the local pH at a tumour site is closer to 7. Another factor of concern is the
increased complexity that is being introduced. Is it because the DNA-based idea
does not carry a suﬃcient amount of drug?
1 L. Song, V. H. B. Ho, C. Chen, Z. Yang, D. Liu, R. Chen and D. Zhou, Adv. Healthcare Mater.,
2013, 2, 275–280.
Nguyen T. K. Thanh opened the discussion of the paper by Edman Tsang: How
did you inject the magnetic nanoparticles into the rat brain?
Edman Tsang responded: Before the micro-surgery, the SD (Sprague Dawley)
rats were rst anesthetized with sodium pentobarbital (60 mg kg1; i.p.; Saggit-
tal). A small 1 cm midline sagittal skin incision was cut approximately on the
scalp to expose the skull. Two holes (Bregma: +0.05 cm, Medline: 0.1 cm) with a
diameter of 0.2 cm were stereotaxically drilled in the skull for the injection of
particles into the le hand side of the sub-ventricular zone (SVZ). The particles
(5 ml, 2000 mg ml1) were then stereotaxically administered into the target sites
(Dura:0.5 cm; 1 ml min1) and were allowed to incubate for diﬀerent amounts of
time (0 hour [n ¼ 5], 1 hour [n ¼ 5], 3 hours [n ¼ 5], 6 hours [n ¼ 5] and 24 hours
[n ¼ 5]).
Nguyen T. K. Thanh remarked: Could you please comment on the translational
aspect of this technology? How close is it to the clinical trial? What else is needed
to be done before neural stem cell therapies can be a reality? What type of rats did
you use; you mentioned Institute of Cancer Research rats?
Edman Tsang answered: Magnetic separation of biological species, magnetic
hyperthermia and magnetic controlled drug release using modied magnetic
nanoparticles have already found clinical applications. The use of iron oxide
based magnetic nanoparticles in particular is deemed acceptable with FDA
approval. However, the technique involving the use of such particles to extract
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neuron stem cells from a live brain in vivo has only recently been disclosed by our
group. We are at the stage of rening and optimizing important parameters such
as minimization of unnecessary damage to underneath brain tissue and reduc-
tion in the retention of magnetic particles in the living brain, etc. These are
important parameters that we need to address before any further clinical trial is
undertaken. We are therefore unable to put forward a timeline but so far the
results look encouraging. The type of rat: SD (Sprague Dawley) rats (male and
female), 150–180 g. The animal experiments have been carried out with our
research partners: one based at Hong Kong Baptist University and the other at the
Taiwan Mouse Clinic.
Dejian Zhou said: Where are the magnetic nanoparticles located? On the
inside or outside of the cells?
Edman Tsang replied: Initially the magnetic nanoparticles are attached to the
exterior of the cells due to the surface recognition groups (CD133+). However,
confocal microscopy showed that some magnetic particles are internalised into
the cells depending on various factors such as incubation time and particle
concentration.
Dejian Zhou said: Have you determined whether the magnetic nanoparticles
are located inside or outside of the cell surface? This can be done by cryo-TEM
imaging by which we have recently shown that nanoparticles are mostly trapped
in endosome-like intracellular compartments aer cell uptake.1
1 L. Song, V. H. B. Ho, C. Chen, Z. Yang, D. Liu, R. Chen and D. Zhou, Adv. Healthcare Mat.,
2013, 2, 275–280.
Edman Tsang responded: Thank you for the suggestion of using cryo-TEM
imaging. Although the confocal microscopy shows evidence for the internaliza-
tion of these particles into the cells the image resolution is not satisfactory. The
mentioned technique could be useful for further study in this area.
Dejian Zhou remarked: When cells diﬀerentiate, where do the nanoparticles
end up?
Edman Tsang answered: This is an interesting question. The simple answer is
that we do not know as we have not yet monitored the diﬀerentiation process of
cells in the presence of the magnetic nanoparticles. Their presence and their
location could be important regarding cell diﬀerentiation.
Asterios Gavriilidis asked: How do the microemulsion properties aﬀect
nanocomposite shell thickness?
Edman Tsang responded: Basically, the thickness of the silica shell increases
as the amount of TEOS increases; a situation in which core-free silica particles
appear when the concentration of TEOS is too high should be avoided. Also, there
are other minor factors that can aﬀect the shell thickness e.g. the ratio of base to
amphiphilic surfactant, reaction time, the size of aqueous domains and the
Discussions Faraday Discussions
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss.
Pu
bl
ish
ed
 o
n 
15
 Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
on
 0
3/
02
/2
01
5 
21
:0
2:
52
. 
View Article Online
number of hydrophobic NPs added into this system, etc. For detailed information
please refer to the paper titled “Fe3O4@SiO2 Core/Shell Nanoparticles: The Silica
Coating Regulations with a Single Core for Diﬀerent Core Sizes and Shell
Thicknesses”.1
1 H. L. Ding et al., Chem. Mater., 2012, 24, 4572–4580.
Asterios Gavriilidis remarked: What is the reason for some nanoparticles
having two iron cores?
Edman Tsang answered: There are many possible reasons leading to two iron
cores in the same shell, which has been commonly observed when core–shell
particles are synthesized via a reverse micro-emulsion technique. However, we
believe that the main reason in our case is that the number of magnetic nano-
particles added (excess) did not match with the number of aqueous domains
(micelles) in the reverse micro-emulsion system, hence two iron cores shared the
same shell. It should be noted that it is very diﬃcult experimentally to match their
numbers.1 However, by optimizing our system, we managed to produce 90% of
our Fe3O4@SiO2 particles with a single core (please refer to the low magnication
TEM image Fig. S2 in the supporting information of our paper (Faraday Discuss.,
2014, DOI:10.1039/C4FD00132J)).
1 H. L. Ding et al., Chem. Mater., 2012, 24, 4572–4580.
Sara Carreira said: How many of the magnetic NPs attach to the surface of the
neural stem cells in vivo? Can you at least estimate it, maybe from the number of
CD133 receptors present on the cell surface?
Edman Tsang responded: We are at present unable to give the number of
magnetic NPs that attach to each neural stem cell (NSC). It is evident that the
process of attachment of ependymal cells by magnetic NPs is rather dynamic in a
living subject. They continue to attach and detach in a owing uid and can also
be taken up by inner cells. As we mentioned in the article, several processes have
to be considered: (1) the diﬀusion and adsorption of particles on NSCs, (2) the
removal of particles by cerebrospinal uid (CSF), (3) dynamically binding/(4)
unbinding to NSCs and (5) internalization of bound particles by NSCs. Accord-
ingly, the initial decrease in the T2 CNR signal can be attributed to the higher rate
of particle removal (processes 2 and 4) compared to the counter processes (1), (3)
and (5). In order to eﬀectively isolate the NSCs magnetically we injected excess
magnetic NPs for maximal attachment, however, we are not yet able to estimate
the number of magnetic NPs on a single NSC.
Katherine Brown said: Are you able to determine or quantify the amount of
active antibody on your nanoparticles?
Edman Tsang replied: We incubated excess antibodies to the given weight of
nanoparticles aer chemical functionalization (see the Experimental section of
our paper (Faraday Discuss., 2014, DOI: 10.1039/C4FD00132J)) in order to maxi-
mize the carrying capacity of the nanoparticles and reducemultiple attachment to
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two or more nanoparticles. However, we did not determine the exact amount of
graed antibody per nanoparticle. No doubt that diﬀerent morphological forms
of bound antibodies of diﬀerent activities arise. We are currently working to
quantify their attachment, morphology and their activity.
Hedi Mattoussi asked: Is there a minimum required number of antibodies
attached to a nanoparticle to promote strong binding onto the target cell
membranes?
Edman Tsang answered: In our experiment, we aimed to attach as many
antibodies as possible to a single nanoparticle. This not only enhances its chance
of binding to the CD133 receptors of a neuron stem cell (NSC) but it also
strengthens the interactions between the composite particle carrying the anti-
bodies and NSCs through multiple antibody–antigen bonds (surface recognition
groups). As a result, we have not yet studied the minimum number of antibodies
per particle for the binding of NSCs. It is noted that the binding force between
such particles and NSCs could depend on their relative numbers and morphol-
ogies, which are rather diﬃcult to assess.
Matthew Todd asked: If the aim of using a nanoparticle appended to an
antibody is to extract cells, don't you ideally want one antibody per particle? That
way you will have multiple nanoparticles attached per cell, increasing the chance
of extraction. On the other hand, if you make particles each appended to multiple
antibodies, you will more likely achieve aggregation behaviour, since one particle
could (cross-)link to multiple cells.
Edman Tsang answered: Thank you for your interesting suggestion. However,
we feel that it is rather diﬃcult to engineer one single molecule on a single
particle surface since chemical modication is normally carried out on a generic
surface with many related energetic surface sites. Although there are reported
methods to immobilize a single guest molecule on a particle surface, the process
is always time consuming and complicated.1 This is achieved by limiting the
chemical functionalities on a single particle; the stability of this antibody–particle
ensemble through limited surface bonding is still open to question. Thus for us, a
more practical way is to gramore than one guest molecule onto a single particle.
We understand the concern of aggregation, however, the relative size of the
magnetic nanoparticle is about 50 nm and the size of the CD133+ cell (antigen) is
tens of microns. Thus, there will not be many cells that can be spatially attached
to the magnetic nanoparticle–antibody composite. Besides, the antibody–antigen
composite is highly specic and complimentary recognition groups must be
present between them before they can be attached in a specic orientation. We
feel the chance of the same bound antibody becoming xed with one antigen to
bind with another bound antibody and leading to extensive aggregation is not
high.
1 M.-L. Ho et al., J. Phys. Chem. C, 2009, 113, 1686–1693.
Nguyen T. K. Thanh said: Your work is so fascinating, so I hope you do not
mind another question.
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You said that you would like to isolate a single cell, but that would be very hard
with magnetic separation, how will you tackle this?
Edman Tsang answered: We are pleased that this new work is appreciated by our
fellow researchers. Yes, it will be a very challenging goal. Firstly, according to our
results, the neuron stem cells (NSCs) appear to be located in specic areas of a living
rat brain rather than being evenly distributed on all brain tissue. Specically, they are
located by MRI in the epithelial regions of ventricles and SVZ areas. However, there is
no information on how these NSCs are distributed depth-wise. On the other hand,
many brain diseases are thought to relate to their deprival in some functional areas. It
will therefore be exciting tomove the NSCs from rich areas to decient areas in future
nano-surgery. At this stage, we are unfortunately unable to image themwith suﬃcient
resolution in order to diﬀerentiate them on a single cell basis. To move this research
forward, we believe the rst stage is to achieve single cell imaging of our optimized
particles (t1/t2 optimization). Then we would be able to relocate each of them by
magnetic means in a highly precise way (computer aided technology). We agree that
the magnetic separation would depend on the overall magnetic susceptibility of the
particles (the total volume of the magnetic phase). In order to achieve this goal, we
would need to design the particles with a high response as well as a small but strong
magnetic probe for computer operated relocation for the required precision.
Peter Dobson opened the discussion of the paper by Oliver Reiser: I believe
that the particles you refer to in your work are ferromagnetic so the magnetic
moments will be much larger than the superparamagnetic iron oxide particles
that have been referred to in earlier papers in the meeting.
Oliver Reiser responded: Yes, this is correct. The "naked" carbon coated
nanoparticles have a magnetic moment of approx. 140–150 emu g1, which will
decrease once you attach molecules, for example polymers. We feel that this can
be an advantage since you are able to generate highly functionalized materials
that still have a considerable high magnetic moment, but the disadvantage is that
agglomeration, especially with the unfunctionalized particles, is more severe.
Peter Dobson commented: Because the particles are ferromagnetic with a fairly
high magnetic moment, they will be diﬃcult to disperse I believe?
Oliver Reiser replied: The unfunctionalized particles are not dispersible, e.g. in
water. With the appropriate coating, i.e. the PEI coating shown here (and
described in our paper (Faraday Discuss., 2014, DOI: 10.1039/C4FD00108G) the
particles are perfectly dispersible in water.
Edman Tsang asked: In the encapsulation of a metal phase by carbon nano-
tubes and related structures, there is a defective region in the carbon structure
which may lead to leaching of the metal phase into corrosive solution. Has this
been observed in your experiments? Are any measures to reduce such metal
leaching in place?
Oliver Reiser responded: Thank you for this important comment. We
constantly discuss this with our collaborators at the ETHZ who manufacture the
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particles. In fact, we have noticed diﬀerences in quality in various batches that we
have received from them (you can easily check by adding EDTA to see if you extract
cobalt). TURBOBEEDS who sells the particles is therefore performing quality
checks to make sure that they not distribute particles which have such eﬀects that
would cause metal leaching. All in all, credit to the procedure developed at the
ETHZ as the coating is generally uniform to prevent metal leaching.1
1 R. N. Grass, E. K. Athanassiou, W. J. Stark, Angew. Chem., 2007, 46, 4909.
Edman Tsang commented: Is there any issue in the material preparation that
means that encapsulated metal particles are not totally separated from each
other. Would this create a problem in magnetic separation if they were actually
aggregated during graphitization?
Oliver Reiser replied: Thank you for the question, all credit goes to our
collaborators at ETHZ who manufacture the particles.1 Based on TEM analysis of
these particles, single entities and non-aggregated ones are formed during
graphitization, so we did not run into this problem. Magnetic separation works
very well with these particles.
1 R. N. Grass, E. K. Athanassiou, W. J. Stark, Angew. Chem., 2007, 46, 4909.
Dejian Zhou said: Are these magnetic nanoparticles cytotoxic? The stability of
the amine graedmagnetic nanoparticles can be further stabilised by PEGylation.
We have found that PEGylated nanoparticles can sustain freeze-drying without
undergoing aggregation.
Oliver Reiser responded: Thanks for the comment and suggestion. We do not
yet know the cytotoxicity of the particles, but it is currently under investigation by
our colleagues in bioanalytics. Thank you also for pointing out the PEGylation –
we need to look into this more. We have some preliminary results though that
PEGylated PEI nanoparticles are less stable than the PEI only particles.
Liane Rossi commented: Regarding the stabilization of the cobalt nano-
particles against oxidation: is it related to the carbon-coating or a matter of
particle size?
Oliver Reiser responded: The stabilization is due to the thin (3–5 layers) gra-
phene-type layer around the particles.
Liane Rossi commented: What characterization techniques were used to show
that the cobalt nanoparticles are metallic and do not oxidize aer exposure to air?
Oliver Reiser replied: The following work was not done by us but by our
collaborators (Prof. W. Stark, ETH Zurich; Turbobeeds Inc.) who manufacture the
nanoparticles:
A combination of three methods was used:
a) X-ray diﬀraction to validate the identity of the metallic crystalline phase. No
oxidic phases could be identied.
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b) Magnetic measurements; cobalt oxide is not ferromagnetic, so any satura-
tion magnetization has to be allocated to the metallic phase. The saturation
magnetization of the carbon coated cobalt nanomaterials is very close to the
saturation magnetization of bulk cobalt.
c) Thermogravimetry: Due to the weight gain upon oxidation of the metallic
material at elevated temperatures (at 400 C) to the oxides, the initial metal
content can be calculated.
Nguyen T. K. Thanh commented: Did they determine that it is a graphene layer
on the surface of nanoparticles, and not any other form of carbon?
Oliver Reiser replied: Yes, our collaborators at the ETHZ did Solid State NMR,
Raman, IR and also measured electronic transport, everything – as well as the
chemical reactivity we see – is consistent with a graphene-like surface.1
1 W. Stark et al., Acc. Chem. Res., 2013, 47, 2297.
Matthew Todd commented: Covalent attachment to a nanoparticle means that
the attached compound is xed to the surface. p-p attachment is interesting
because the appended species could move over the surface. This could, for
example, permit initial binding interaction followed by the slower development of
polyvalency in binding. Do you see evidence of such movement on the surface?
Oliver Reiser answered: We have deposited Pd-nanoparticles on the carbon
surface of the magnetic nanoparticles, and indeed, we see movement here in ref. 1.
We also see that the attachment through p-stacking (pyrene) units is reversible with
temperature, so indeed I would expect to have movement on the surface.
1 Q. M. Kainz et al., Adv. Funct. Mat., 2014, 24, 2020.
Nguyen T. K. Thanh asked: In Fig. 2 (in Faraday Discuss., 2014, DOI: 10.1039/
C4FD00108G) you mentioned: “The dispersibility of 12 was by far superior in
dichloromethane than in water.”
There are some ligand-ligand interactions, and 12 might not form a well-
packed passivating layer due to side chain packing/bonding properties.
We have studied the eﬀect of 58 diﬀerent peptide sequences on the electrolyte-
induced aggregation of the nanoparticles in our paper.1
1 R. Levy, N. T. K. Thanh, R. C. Doty, I. Hussain, R. J. Nichols, D. J. Schiﬀrin, M. Brust, D. G.
Fernig, J. Am. Chem. Soc., 2004, 126, 10076–10084.
The stabilities conferred by the peptide ligands depended on their length,
hydrophobicity, and charge.
Oliver Reiser replied: Yes, very nice work, and I completely agree with your
statement that the stability of the dispersions is dependent on length, hydro-
phobicity, and the charge of the outer layer. What we wanted to show with Fig. 2 in
our paper (Faraday Discuss., 2014, DOI: 10.1039/C4FD00108G) is that (1) typical
coatings like MeOPEG 2000 that have been shown to stabilize metaloxide nano-
particles are not suﬃcient for the highly magnetic metal particles we have studied
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and (2) that seemingly very similar coatings (e.g. compare 12 and 16) can still
confer quite diﬀerent stabilities to the nanoparticles.
Nguyen T. K. Thanh asked: If the nanoparticles are polydisperse, diﬀerent
sized particles would not only have diﬀerent physical properties, but they
would also have diﬀerent surface areas. Therefore, the coating might not be
so eﬀective, as diﬀerent curvatures require diﬀerent coatings (e.g. molecular
structures). Moreover, they would have diﬀerent numbers of active molecules,
such as antibodies. So, the bioactivities are also diﬀerent; this would cause non-
reproducibility of subsequent biological assays.
Oliver Reiser replied: Thank you, this is a very good comment, and we will need
to address this when we move to biological assays. The nanoparticles have by and
large a diameter of 50 nm, but indeed, smaller particles are also present.
Hedi Mattoussi remarked: We know that cobalt metal is easily oxidized by
simple exposure to air and/or water.
Does the graphene protective layer used in your Co nanoparticles provide
enough shielding to avoid the issue of cobalt oxidation?
Oliver Reiser answered: Yes, while the oxidation of metallic cobalt surfaces
even occurs at room temperature the carbon layer shields the surface from this
oxidation. This can be evidenced by diﬀerential calorimetry combined with
thermogravimetry, where no material oxidation (¼ weight gain and energy
release) is observed at temperatures <180 C. Similarly, the oxidative properties in
water over a wide pH range have been quantied by leaching studies over the
course of several weeks1 and support the excellent shielding properties of the
carbon layers. Our collborators at ETH Zurich and Turbobeeds who manufacture
the particles have been using the materials for more than seven years, and still
have old samples – they can nd no indication of cobalt oxidation during storage
at ambient conditions over this time frame.
1 A. Schaetz et al., Chem. Eur. J., 2011, 17, 10566–10573.
Catherine Amiens said: When you functionalised the graphene layer around
the cobalt nanoparticles, you either use or create defects. Does it alter the
protection that this graphene layer aﬀords against oxidation of the cobalt core?
Oliver Reiser answered: The functionalization takes place only on the rst
carbon layer exposed to the surface. Since there are multiple carbon layers around
the nanoparticle (3–5), the stabilization is not aﬀected.
Catherine Amiens commented: To estimate the mobility of the ligands phys-
isorbed on the graphitic surface, you could work with ligands bearing radicals at
the end of their chains (such as TEMPO).
This method has been followed by V. Chechik to demonstrate the mobility of
thiols on nanoparticles.1
1 P. Ionita, A. Volkov, G. Jeschke, V. Chechik, Anal. Chem., 2008, 80(1), 95–106.
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Oliver Reiser replied: Thank you for this excellent suggestion, we will denitely
follow up on this, especially, since we had have already experience with (covalently
bound) TEMPO to these nanoparticles.1
1 A. Schaetz et al., Chem. Eur. J., 2008, 14, 8262.
Edman Tsang asked: The total encapsulation of graphitic layers on Co particles
is rather challenging to achieve. The Co particle may have diﬀerent shapes and
crystallographic facets. The graphitic layers composed of sp2 carbon atoms are
also spatially rigid, and hence will not be able to join up seamlessly around the
particle to oﬀer the perfect encapsulation. My main question is are there
substantial defect regions between the junctions of the graphitic layers, particu-
larly at the interface between the metal facets that cause metal leaching into the
solution?
Oliver Reiser answered: Thank you, this is a point well taken, and we
constantly discuss this with our collaborators at the ETHZ who manufacture the
particles. In fact, we have noticed diﬀerences in quality in various batches we have
received from them (you can easily check by adding EDTA to see if you extract
cobalt). TURBOBEEDS, who sells the particles, is therefore performing quality
checks to make sure that they not distribute particles that would cause metal
leaching. All in all – credit to the procedure developed at the ETHZ the coating is
generally uniform to prevent metal leaching.1
1 R. N. Grass, E. K. Athanassiou, W. J. Stark, Angew. Chem., 2007, 46, 4909.
Maya Thanou opened the discussion of the paper by Kerry Chester: Are there
any potential risks in the use of dextran sulfate as a plasma expander?
Kerry Chester answered: To the best of our knowledge, unsulfated dextrans are
the agents clinically used as plasma substituents.1,2 Dextran sulfate 500 has been
used clinically as an anti-coagulant (as it is a synthetic analogue to heparin)3 and
an antilipemic, as well as an antiviral against human immunodeciency virus
(HIV);4 it was shown that dextran sulfate inhibits the binding of viruses to target
cells and was used as an anti-HIV agent in patients with AIDS. However, in the
doses applied it showed limited anti-viral eﬃcacy as well as some toxicities (like
reversible thrombocytopenia and alopecia) and was not taken further as an
antiviral agent.5
1 C. Y. Quon, Clinical pharmacokinetics and pharmacodynamics of colloidal plasma volume
expanders, Journal of Cardiothoracic Anesthesia, 1988, 2, 13–23.
2 R. McCahon and J. Hardman, Pharmacology of plasma expanders, Anaesthesia and
Intensive Care Medicine, 2010, 11, 75–77.
3 K.Walton, Experiments with dextran sulphate as an anticoagulant, Proc. R. Soc. Med., 1951,
44, 563–4.
4 H. Mitsuya, D. J. Looney, S. Kuno, R. Ueno, F. Wong-Staal and S. Broder, Dextran sulfate
suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells,
Science, 1988, 240, 646.
5 C. Flexner, P. A. Barditch-Crovo, D. M. Kornhauser, H. Farzadegan, L. J. Nerhood, R. E.
Chaisson, K. M. Bell, K. J. Lorentsen, C. W. Hendrix and B. G. Petty, Pharmacokinetics,
toxicity, and activity of intravenous dextran sulfate in human immunodeciency virus
infection.1
1 C. Flexner et al., Antimicrob. Agents Chemother., 1991, 35, 2544.
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Maya Thanou remarked: Near IR uorescence may be aﬀected (quenched)
depending on the distance from the core NP and or the density of graing. Do you
observe such a phenomenon?
Kerry Chester replied: This is an interesting point, but we have not attempted
to measure quenching.
Nguyen T. K. Thanh remarked: In your paper you wrote: "We therefore devel-
oped methods to functionalize SPIONs with near-infrared (NIR) dyes in order to
trace their biodistribution" In Fig 6 in your paper, it says "NIR signal of SPIONs in
bloodmeasured on Odyssey scanner". Could you please clarify how you trace their
"biodistibution"?
Kerry Chester replied: We only measured the blood but in vivo imaging can be
done using a mouse pod attached to the LiCor Odyssey scanner: http://
www.licor.com/bio/products/accessories/odyssey/mousepod/. Examples of some
papers that used the scanner to trace and quantify dye labelled conjugates in vivo
can be found in refs. 1–4.
1 J. L. Kovar, M. A. Simpson, A. Schutz-Geschwender, D. M. Olive, A systematic approach to
the development of uorescent contrast agents for optical imaging of mouse cancer
models, Biochemistry, Faculty Publications, 2007, 9.
2 J. L. Kovar, W. Volcheck, E. Sevick-Muraca, M. A. Simpson and D. M. Olive, Character-
ization and performance of a near-infrared 2-deoxyglucose optical imaging agent for
mouse cancer models, Anal. Biochem., 2009, 384, 254–262.
3 J. L. Kovar, W. Volcheck, J. Chen and M. A. Simpson, Purication method directly inu-
ences eﬀectiveness of an epidermal growth factor-coupled targeting agent for noninvasive
tumor detection in mice, Anal. Biochem., 2007, 361, 47–54.
4 L. Sampath, S. Kwon, S. Ke, W. Wang, R. Schiﬀ, M. E. Mawad and E. M. Sevick-Muraca,
Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal
growth factor receptor 2 overexpression in breast cancer, J. Nucl. Med., 2007, 48, 1501–
1510.
Maya Thanou asked: At what time post-injection can you observe NIRF in the
blood samples?
Kerry Chester replied: We have only investigated the NIR signal 1 hour post
injection but it will be interesting to further investigate the fate of the NIR labelled
SPIONs at diﬀerent time points.
Hedi Mattoussi questioned: (1) Does the sulfate agent used in your experiment
block binding to cells by interacting with the receptor(s) or by interacting with the
nanoparticle itself?
(2) Have you considered using polyethyelne glycol (PEG) to coat the nano-
particle surfaces as a means of reducing nonspecic interactions?
Kerry Chester answered: (1) We have not carried out a formal experiment but
our working hypothesis is that dextran sulfate 500 interacts with the receptors and
not the SPIONs themselves. Ferucarbotran is rapidly cleared from circulation
mainly (but not exclusively) by the scavenger receptors present on the liver
Kupﬀer cells. Dextran sulfate 500 is a known blocker of this type of receptor and
we achieve blocking more eﬀectively when we give dextran sulfate 500 at 2 and
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24 hours prior to Ferucarbotran than when we give both agents simultaneously.
Furthermore, both Ferucarbotran and dextran sulfate 500 are negatively charged,
suggesting that direct interactions with each other are less likely. Please refer to
the rst and third paragraph of the paper discussion for references.
(2) Yes, we have considered PEG but have not yet explored this option for
clinical use for a number of reasons, including the complexity, heterogeneity and
biodegradability of PEGylated products and our experience that, in some
instances, PEG modication of SPIONs can increase unspecic or untargeted
internalisation and uptake (see reference 37 in the paper).
Maya Thanou enquired: For NP injected directly into the brain, is a stealth
coating required?
Kerry Chester responded: Within the brain tumour microenvironment there
are a range of cell types which include: tumour core, microglial cells (brain
macrophages), astrocytes, oligodendrocytes and neurons. All these cell types
could take up the SPIONs, specically the macrophages. Therefore, despite the
possible evasion of the RES by direct intratumoural injection of SPIONs, stealth is
still advisable.
Dejian Zhou opened the discussion of the paper by Benjamin P. Burke: Where
are the gallium ions loaded on the magnetic nanorods?
Benjamin P. Burke answered: This is a question that we are very interested in
answering but have not yet identied an experiment to satisfy our curiosity. The
issue lies in the potential diﬀerence between the larger amounts of gallium(III) used
in a standard characterisation experiment and the picomolar amounts of radio-
active gallium ions. It has proved challenging to assign data in some spectroscopic
methods used to analyse the non-radioactive gallium(III) species, due to overlap of
Fe–Si and Fe–O stretches. Even if an assignment could be made it may not be an
analogous mechanism for the much smaller amounts of radioactive gallium.
It is interesting to note that the formation of stable multinuclear gallium oxide
cations has been observed in zeolite pores.1 This could be of relevance to the
observed high stability interaction with the silica surface.
1 E. A. Pidko et al., Phys. Chem. Chem. Phys., 2009, 11, 2893–2902.
Tom Berkleman asked: Could you be seeing deposition of gallium oxide,
perhaps templated or promoted by your silica layer?
Benjamin P. Burke replied: This is one possible mechanism. However, it seems
unlikely that it would be a coating, as the radiosynthesis is carried out at acidic pH
and the subsequent stability is high. We think that it is more likely to be a gallium
species (which could be oxides or hydroxides) formed in pores on the silica
surface. This hypothesis requires further investigation (see also the answer to the
previous question).
Sara Carreira asked: What was your motivation for using rod-shaped particles
rather than spherical ones? Are there any advantages of using that shape?
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Maya Thanou asked: Rods interfere with the cell membrane in a diﬀerent way to
spherical nanoparticles. What is the rationale of using rods for this application?
Benjamin P. Burke answered both questions: Rod shaped particles were
selected in part for reasons of curiosity. Iron oxide based PET/MR imaging agents
have been developed a handful of times previously, but always using nano-
spheres. We wanted to see if we could not only develop a novel method of radi-
olabelling for PET, but also using a previously untested core material shape. We
anticipate that similar procedures will be equally valid with spherical iron oxide
nanoparticles. The literature is less well developed for iron oxide nanorods than it
is for nanospheres, however preliminary studies oﬀer possible advantages in
magnetic susceptibility and cell penetration.
Nguyen T. K. Thanh asked: What is the crystal phase of your iron oxide
nanorods?
Benjamin P. Burke answered: The preparation of iron oxide nanorods in this
publication utilises literature methods (references 42 and 43 in our paper) which
are known to form magnetite.
Nguyen T. K. Thanh remarked: What do you think about the regulatory issues
of such a novel ligand for clinical use?
Benjamin P. Burke responded: Novel MRI contrast agents have to meet the
standard regulations and approval processes for the use of new agents in humans.
The key advantage of this work is its potential applicability in the modication of
currently licensed agents to a form of PET/MRI multimodal imaging constructs.
Nguyen T. K. Thanh asked: How do you quantify the radioactive dose if your
particles are very diﬀerent sizes?
Benjamin P. Burke replied: The radioactive dose is quantied as activity (MBq)/
Fe weight (g) and is therefore not size dependent.
Edman Tsang remarked: Are there any advantages or disadvantages of your
approach compared to other labelling techniques?
Benjamin P. Burke answered: The advantages come from the simplicity of the
approach: the preparation is facile as no chelator is attached to the surface, only short
heating times are needed and it is a nal step radiolabelling process. The tracer can
therefore be produced rapidly (which is an important issue with short lived radio-
isotopes). The biggest disadvantage is the temperature required for the radiolabelling
reaction, which could lead to stability issues with some surface coatings.
Edman Tsang asked: Would any radioactive species leach out to the external
environment when applied ?
Benjamin P. Burke replied: During in vitro experiments using human serumwe
see no evidence of radioactivity being transchelated to transferrin at up to 3
Discussions Faraday Discussions
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss.
Pu
bl
ish
ed
 o
n 
15
 Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
on
 0
3/
02
/2
01
5 
21
:0
2:
52
. 
View Article Online
hours, which is the maximum applicable time for acquiring image data using the
short lived 68Ga isotope.
Matthew Todd remarked: The outlier result from the Ga labelling in Figure 3 is
the increase in size for 5. Does this imply that the metal is loosely chelated by
something other than the macrocycle, and in a way that leads to aggregation of
several rods through chelation of a metal by more than one rod?
Benjamin P. Burke replied: Although the proposed mechanism is possible, we
believe it to be temperature related. Reactions with 68Ga at room temperature do
not seem to cause aggregation. In our opinion the most likely explanation is
temperature based aggregation of PEG chains, which is documented.
Amelie Heuer-Jungemann opened the discussion of the paper by Nguyen TK
Thanh: Have you encountered any problems during the coupling, e.g. aggregation
due to one glutaraldehyde molecule coupling to two diﬀerent particles?
Lanry L. Yung asked: Can you give any information about the experimental
design, with regard to minimizing particle crosslinking when functionalizing the
surface of the particles with glutaraldehyde?
Edman Tsang asked: How can you avoid the problem of condensation between
amine and aldehyde onto the same particle?
Nguyen T. K. Thanh responded to all three questions: In our experiment we
used huge a excess of glutaraldehyde (GA). Density of GA per nm2: 4.10  108.
therefore each particle is immediately coated with GA, so we did not observe any
cross linking.
Paresh Ray queried: How many antibodies are attached to each particle?
Nguyen T. K. Thanh answered: We do not normally calculate the number of
antibodies attached to each particle, for further information please see:
B. Kozissnik, L. A. W. Green, K. Chester and N. T. K. Thanh, Strategy for functionalisation of
magnetic nanoparicles for biological targets, in Magnetic nanoparticles: from fabrication
and clinical applications, ed. N. T. K. Thanh, CRC Press, Taylor and Francis, Boca Raton,
London & New York, 2012, pp. 129–150.
Tom Berkleman said: I would like to point out that with the high concentration
of glutaraldehyde used, it would be in orders of magnitude excess over the amine
functionality on the surface of the nanoparticle. You actually wouldn't expect
much crosslinking.
Nguyen T. K. Thanh answered: We agree.
Scott Mitchell asked: In terms of control experiments for the interactions with
V. cholerae bacteria, I was wondering what the TEM images of the IONPs@CHI
look like. Do the IONPs@CHI interact in the same way as the complex of ION-
P@CHI@GA@PrA@Ab? Surely this is an essential control that must be shown to
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test the hypothesis of the presence and importance of the Ab conjugated to the
polymer matrix? It is an important study to show: Abs are expensive, so in this
case are they really necessary?
Furthermore, what about the toxicity of the IONPs@CHI and IONP@
CHI@GA@PrA@Ab? The growth of the bacteria appears to be aﬀected in the TEM
images. Did the authors carry out Resazurin cell viability assays (or similar) to
quantify the toxicity of the particles, or lack thereof?
Nguyen T. K. Thanh responded: It is clearly stated in the paper: “For positive
controls, the solutions containing IONP@CHI and ION- P@CHI@GA@PrA were
incubated with V. cholerae bacteria diluted in water from an initial concentration of
103 cfumL1. The same procedures used for testing the IONP@CHI@GA@PrA@Ab
complex were followed. A signicant number of nanoparticles were found clustered
on the grid, but no V. cholerae bacterial cells were found (data not shown).” I do not
see the relevance of cell viability assays in this work.
Dejian Zhou said: How stable is your magnetic nanoparticle-protein A conju-
gate? Are the results repeatable aer being stored for an extended period? This is
important in terms of practical applications. For example, we have found that our
covalently conjugated magnetic nanoparticle-DNA conjugate is stable for about 6
months,1 which is oen considered the minimum stability requirement for
commerical reagents.
1 Y. Zhang, C. Pilapong, Y. Guo, Z. Ling, P. Quirke and D. Zhou, Anal. Chem., 2013, 85, 9238.
Nguyen T. K. Thanh replied: To retain the bioactivity of protein A molecules,
their stability can be maintained for years if kept at 20 C. In our experiments,
the conjugate was tested every month; during the rst 3 months in storage at 4 C
we did not see any diﬀerence in the tested results between diﬀerent time points.
We expect it to remain stable for even longer.
Dejian Zhou remarked: Detection of bacteria in your method takes place by
SEM or TEM – can you quantify the number of bacteria? What is the dynamic
range of detection?
Nguyen T. K. Thanh responded: In our method, the number of bacteria can be
quantied by TEM or SEM.We reported that the conjugate could easily separate V.
cholerae bacteria from water samples at concentrations as low as 10 cfu mL1 by
TEM observation.
Liane Rossi asked: Did you reduce the imine group obtained by the conden-
sation of the aldehyde group of glutaraldehyde and the terminal amino group on
the nanoparticle surface? Please add this information in the experimental
section.
Nguyen T. K. Thanh answered: No, we did not.
Lucio Litti commented: You used imine formation to cross-link the nano-
particle and protein A. As you know, Schiﬀ bases are pH-sensitive and can
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undergo hydrolysis. Did you verify the stability of your systems in terms of protein
A antibody release in aqueous media? On the other hand, you could use the
complete hydrolysis of your Schiﬀ bases for a quantitative estimation of the total
number of antibodies loaded onto your nanoparticles.
Nguyen T. K. Thanh replied: We used an excess of glutaraldehyde in the
conjugation step. The imine hydrolysis is assisted through the use of an acid
catalyst. Under our conditions, the nal products IONP@CHI@GA@PrA@anti-
body were formed, and evidently they were selectively bound to the bacteria. We
tested our conjugates aer three months and they were still stable.
Kerry Chester opened the discussion of the paper by Ivan Parkin: In Figure 2 in
the paper there appear to be particles that are rod-shaped and others that are
spherical, why is this?
Ivan Parkin replied: This is because they are of diﬀerent types of material – one
is due to the iron oxide (spherical) and the other to rhenanite (rods).
Kerry Chester asked: Is there a way to control the synthesis process to obtain
uniform particles?
Ivan Parkin answered: We are looking into this but do not have a synthesis for
mono-dispersed particles. We will be exploring a microuidics approach outlined
in Scheme 1 in our paper "Sample (I) is the route to iron oxide nanoparticles
proposed by Park et al.3”
Catherine Amiens commented: In your paper you mentioned that nanorods
are epitaxially grown. What do you mean exactly? Do the iron oxide rods grow on
top of the NaCaPO4 ones? What is the epitaxial relationship in this case?
Ivan Parkin replied: The paper has since been rectied, as the rods were not
epitaxially grown, rather the particular blend of surfactants aﬀorded by the shark
liver oil/olive oil mix was enough to promote directional growth of NaCaPO4 (b-
rhenanite) rods. As for iron oxide, there were spherical nanoparticles observed in
the sample, and a little iron content was observed for the rods by EDX spectros-
copy, so the possibility of the growth of the rods from iron oxide nanoparticles
remains a distinct possibility.
Catherine Amiens asked: Do you mean that in the preparation you observe
NaCaPO4 rods and iron oxide rods at the same time?
Ivan Parkin responded: Just the one type of rod was observed, with a portion of
iron oxide nanoparticles. The composition of said rods was diﬃcult to determine,
but is probably NaCaPO4 (b-rhenanite). However the possibility that the rods grew
from a seed iron oxide nanoparticle is possible.
Catherine Amiens commented: Can you please give the mean size of the
nanoparticles used during hyperthermia experiments. It would be useful for
comparison purposes.
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Ivan Parkin replied: From this and previous work, the optimum size for
nanoparticles for hyperthermia are single magnetic domain particles of around
25 nm in size. However this is related to the frequency used in the hyperthermia
system. In theory it should be possible to sweep the frequency of the hyperthermia
apparatus and nd an optimum resonance value that could be used for a wide
range of nanoparticle sizes. However this does not seem to be easy to achieve and
hence we have focussed our eﬀorts on making near monodisperse particles
around the best heating values. In this paper, nanoparticle sizes for magnetic
hyperthermia were recorded as follows: Standard synthesis ~8.5 nm, iron-
palmitate decomposed in 1-octadecene ~10 nm and iron-palmitate decomposed
in 1-octadecene ~12 nm nanoparticles with rods in the order of ~150 nm in length.
Matthew Todd commented: You are applying a eld and generating motion.
Presumably you can run this the other way – move a liquid in which the same
nanoparticles are suspended and generate a eld? I.e. conversion of mechanical
power to electrical?
Ivan Parkin responded: The nanoparticles used in this paper are super-
paramagnetic so do not have a net magnetic moment under normal conditions.
This may be possible with ferrouids of greater particle size.
Nguyen T. K. Thanh asked: In Scheme 1 you state “Sample (I) is the route to
iron oxide nanoparticles proposed by Park et al.,3 Sample (II) is the synthesis of
iron palmitate from high street sources and its subsequent decomposition in
1-octadecene and Sample (III) the decomposition of iron palmitate in shark liver
oil.” In the reprint, SQUID magnetometry shows:
“Samples (I), (II) and (III) have saturation magnetisation values of 52, 2.2 and
0.1 emu per gram, respectively”. Could you please explain why Sample (III) has
lost its saturation magnetisation by ~900 fold?
Ivan Parkin responded: We are not sure why this occurred – probably due to
diﬀerent sized crystallites.
Sandhya Moise asked: What is the dominant mechanism of heat generation
for your nanoparticles during magnetic hyperthermia? What are the eld
conditions used?
Ivan Parkin answered: There are thought to be three mechanisms in operation
– changes in Brownian motion, reversal by thermal activation and suppression of
the anisotropic barrier by a magnetic eld for single domain nanoparticles. For
multidomain particles domain nucleation and domain wall switching can be
important. I am not a physicist but I normally think about this heating eﬀect in
terms of a friction induced by the fact that the external eld can switch faster than
the particles, and the lag generates a heating eﬀect. The eld conditions are
constant and set by the MACH instrument and are as follows: frequency ¼ 945
kHz, eld strength ¼ 6.6 kA m1 with a mass of 1 mg ml1 of iron in the nano-
particles. The coil itself was 6 turns, internally cooled with water, 36 mm in length
with 18 mm internal diameter.
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Peter Dobson remarked: Regarding the mechanisms for hyperthermia, there
are broadly two possibilities. For the larger single domain ferromagnetic particles
the heating eﬀects will be because of magnetic domain reversal; for the smaller
superparamagnetic particles the heating will be associated with the movement of
spins within the particle and this will manifest itself in high losses at certain
frequencies. This requires a more detailed knowledge of the real and imaginary
parts of the magnetic susceptibility of the materials.
Dejian Zhou opened the discussion of the paper by Catherine Amiens: Did you
use any base to deprotonate your carboxylate ligands before ligand exchange?
Catherine Amiens answered: We tried to directly use sodium oleate but the
exchange was still not eﬀective.
Dejian Zhou asked: Both ligands contain just a single carboxylate to coordinate
to the magnetic nanoparticle. The binding strength here may not be strong
enough completely displace the original hyrdophobic ligands. It would be good to
use chelating ligands to increase the binding strength, especially those with a
dendritic shape, which can match the surface curvature of the nanoparticle much
better and hence provide much more stable capping of the nanoparticle
surface.1,2
1 Y. A. Wang, J. J. Li, H. Chen and X. Peng, J. Am. Chem. Soc., 2002, 124, 2293.
2 D. Zhou, Y. Li, E. A. H. Hall, C. Abell and D. Klenerman, Nanoscale, 2011, 3, 201.
Catherine Amiens answered: This is a very good suggestion. We also plan to try
ligands with stronger binding abilities towards the iron surface, such as phos-
phonate end groups.
Edman Tsang asked: Could you rationalize the chemical reactivity of FeBi? In
one instance, Fe is preferentially oxidized but in another instance the reverse is
taking place.
Catherine Amiens answered: As iron is located mainly at the surface of the
nanoparticles it is not surprising that it should oxidize rst. Then in time one can
observe that the core of the nanoparticles is also modied. The long distances
measured on the HREM images are indicative of oxidation, but we could not
determine the type of oxide formed.
Edman Tsang asked: Howmuch scrambling of the atoms within FeBi is taking
place in your system?
Catherine Amiens responded: This is a crucial question. It is indeed very
important to know if there is any redistribution of the Fe and Bi atoms, especially
upon oxidation or aer prolonged exposure to biological media. We are beginning
work on this study, which is highly challenging due to the small size of the
objects.
Edman Tsang said: Did you try EXAFS to characterize your samples?
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Catherine Amiens replied: This has been done in the case of the BiFe150
sample, and was reported in the paper by G. Mattei et al.1 We plan to study the
smaller nanoparticles during our next beamtime.
1 G. Mattei et al., J. Phys. Chem. C, 2013, 117, 1477.
Ivan Parkin remarked: Bismuth is very dense and oen it is hard to prove if a
composite material is formed or if it is a mixture of the elements. We have
previously made BiP and it took over 12 separate techniques to provide proof that
an actual compound, and not an intimate mixture of the elements, had been
formed.
Edman Tsang asked: Have you seen any phase segregation upon oxidation?
Catherine Amiens responded: So far oxidation experiments have been carried
out on already segregated nanoparticles only, i.e. on nanoparticles consisting of a
bismuth core and iron shell.
In this case, HRTEM images clearly show that when working in the solid state,
oxidation can be stopped at the very rst stage when only the iron shell is
oxidized. Upon prolonged oxidation (over weeks), full oxidation of the core is
evidenced, however at this stage we cannot tell if the initial segregation between
Fe and Bi is retained or if some bismuth atoms migrate towards the surface.
This is an important question that we want to investigate further, especially in
the case of oxidation in aqueous solutions, as bismuth leaching would probably
prevent the use of these nano-objects in vivo.
Lanry L. Yung said: Both Prof. Nguyen Thanh and Peter Dobson have
mentioned the potential of applying nanotechnology for applications in infec-
tious disease, such as pathogen separation and diagnostics (Prof. Thanh) and
antimicrobial agents (Prof. Dobson). What are the key issues we should address
from the materials and chemistry point of view?
Peter Dobson replied: There are several requirements for sensing bacteria and
fall broadly into the following categories:
(1) To sense and quantify the presence of bacteria, and to some extent this is
now being done in the food industry but it needs to be more widely adopted. The
methods in current use measure oxygen consumption as an indicator of the
presence of microbes, or, in some cases, the emission of other gaseous products.
(2) There needs to be methods of identifying the species of bacteria present
and quantifying them. This should be very rapid and applied at "point of use".
(3) It is desirable to identify the strain of a bacterium and this will require a
rapid miniature DNA sequencing technique.
Nguyen T. K. Thanh replied: For magnetic detection or separation of patho-
gens you need to have stable superparamagnetic nanoparticles with high
magnetic moments. Also, the nanoparticles should have functional groups that
are specic to the pathogens of interests and have sensitivities that allow early
detection.
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Ivan Parkin observed: Surfaces can also be made antimicrobial by incorpora-
tion of dyes and gold nanoparticles.
Peter Dobson remarked: I was asked to comment on the scientic challenges.
Firstly I suggest that nanoparticles could transform the way we try to design new
antimicrobials; secondly there is still a fundamental question about the nature of
the electron spins at the surface of magnetic particles, and if these diﬀer from the
spins in the bulk of the nanoparticle. These altered spins could be further
modied by the binding of ligands onto the surface. This could have implications
for the design of particles for use in hyperthermia or MRI.
Dalibor Soukup remarked: Currently, interparticle dipole–dipole interactions
seem to be a hot topic in the eld of magnetic hyperthermia. Some papers show
that they can enhance the heating eﬃciency of magnetic nanoparticles, some
show the opposite. They can also reduce the magnetisation saturation, thus
decreasing the heating eﬃciency in turn. What is your opinion on these dipole–
dipole interactions with respect to magnetic hyperthermia? Routinely, magnetic
nanoparticles are tested in solutions in which they are homogeneously distrib-
uted, however, once internalised in cells, they are usually stored in endosomes/
lysosomes where the interparticle distance is much smaller than that in solutions,
which favours dipole–dipole interactions. Do you think there is a need for better
methods of testing that would show biologically relevant heating eﬃciencies?
Peter Dobson responded: This is a diﬃcult question! Frankly I do not know. I
have tried to nd an answer, and a recent paper by M. E. Sadat et al. seems to give
part of the answer to your question and they imply that there are very signicant
diﬀerences between “free” and “conned” nanoparticles.1
1 M. E. Sadat et al., Mat. Sci. Eng., 2014, 42, 52.
Ivan Parkin remarked: In magnetic hyperthermia it is critical to have particles
of exactly the correct size and shape for maximum eﬀect.
Nguyen T. K. Thanh responded: I agree.
Catherine Amiens commented: Dispersibility is not always well described in
the papers.
Most of the time one simply discusses the stability of the colloidal solutions on
the macroscopic observation of the precipitation of nanoparticles with time in
diﬀerent conditions (variation of pH, ionic strength etc.). No microscopic (or even
nanoscopic) description is made of the organisation of the nanoparticles in
solution (real dispersion of small aggregates already forming), although this point
is very important when discussing certain properties e.g. relaxivities in MRI. We
need standard conditions to be able to compare results from one paper to the
other and an agreement on the level of detail (macroscopic or otherwise).
Nguyen T. K. Thanh responded: We need cryo-TEM for the small aggregates
you mention.
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Edman Tsang asked: Is there any subtle change in physiochemical properties
with respect to the change in particle size?
Nguyen T. K. Thanh said: Reproducibility in nanoparticle synthesis is one of the
biggest challenges. The physical properties of nanoparticles depend on their size, but
also the number of ligands coated on the surface. The interaction between ligands is
also dependent on the nanoparticle surface area. Therefore, it is very important to
produce monodisperse nanoparticles. Currently most of the synthesis of nano-
particles is carried out in batch, subjects it to many factors that could aﬀect the
synthesis such as temperature, even at ambient temperature, mixing, and diﬀusion.
Therefore the reproducibility is limited. On a fundamental level, each material will
nucleate and grow depending on its reaction conditions and even a small change in
conditions, such as pH, can lead to a completely diﬀerent mechanism.1
1 N. T. K Thanh, N. Maclean and S. Mahiddine, Chem. Rev., 2014, 114, 7610–7630.
Lanry L. Yung commented: Since research knowledge oen goes missing when
a research student/postdoc leaves the group, I would be interested if anyone has
any suggestions on how to keep knowledge within the research group.
Matthew Todd remarked: The development of new antimicrobial agents is a
continual battle against resistance. It is easier to develop resistance to some
drugs. Is there something unusual about the mechanism of bacterial killing
employed by these surfaces (or indeed nanoparticles more generally) that might
mean the bacteria would nd it challenging to develop resistance?
Ivan Parkin responded: Yes. In general our work on light activated coatings as
antimicrobials functions via the formation of reactive oxygen species and singlet
oxygen. These typically function in a non-specic way to destroy the bacteria
through thousands of possible pathways simultaneously. This is diﬀerent from an
antibiotic which typically has a very small number of pathways to attack the
bacteria. Hence in the radical or singlet oxygen based approach it is very unlikely
the bacteria could develop resistance.
Peter Dobson asked the delegates: How can one measure the temperature
changes in hyperthermia? In fact, one might also call into question the very
meaning of “temperature” at this nano-level.
Yuri Antonio Diaz Fernandez responded: I appreciate this topic being raised,
since it is extremely relevant. The applicability of the denition of macroscopic
temperature on the nanoscale is a fascinating and not always suﬃciently
addressed problem. To my understanding, this question can only be answered in
the context of nonequilibrium thermodynamics and uctuation theory, which,
even aer several years of development, are still works in progress, obscure to
those from other disciplines. Those in the nanomaterial scientic community
who have a particular interest in hyperthermia research, will benet from
establishing systematic discussion opportunities with mathematicians and
experimental and theoretical physicists, bridging the gaps among these elds.
Probably a Faraday Discussion on “Physical Chemistry Experimental Tools and
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Theoretical Concepts Applied at the Nanoscale” could be the best starting point
for this cross-disciplinary exchange. Regarding available methods to characterize
hyperthermia, Pallavicini, Chirico et al. have recently demonstrated an indirect
spectroscopic method able to probe the local temperature on the surface of
diﬀerent nanomaterials used for hyperthermia.1
1 S. Freddi et al., Nano Lett., 2013, 13(5), 2004–2010.
Scott Mitchell also responded: Our group recently published a paper using
DNA conjugated to iron oxide NPs as an indirect method for probing local
temperature on the surface of magnetic nanoparticles during magnetic
hyperthermia.1
1 J. T. Dias, M. Moros, P. del Pino, S. Rivera, V. Grazu´ and J. M. de la Fuente, Angew. Chem.,
2013, 125, 11740–11743.
Maya Thanou raised the question: How would these magnetic nanoparticles
(MNP) compare with already advanced or available MNPs, with respect to their
ability to induce hyperthermia?
Ivan Parkin answered: The particles show good hyperthermia response but
they are not as eﬃcient as the best commercial materials.
Maya Thanou said: Hyperthermia (mild temperature increase) does not kill
tumour cells, however it sensitizes them to other treatments. What other treat-
ments would these be?
Ivan Parkin responded: We have not investigated this. Potential ideas we are
developing include having a lowmelting point wax containing an anticancer drug.
Nguyen T. K. Thanh commented: The thermal energy needed for induction of
cell death has been found to be close to the energy needed for protein denatur-
ation, leading to the conclusion that the main cytotoxic eﬀect of hyperthermia is
based on the denaturation of membrane and cytoplasmic proteins. For more on
this please see ref. 1.
1 A. Hervault and N. T. K. Thanh, Nanoscale, 2014, 6, 11553–11573.
Maya Thanou asked: What is the required time of exposure of tumours to
hyperthermic temperatures for sensitisation?
Nguyen T. K. Thanh answered: Please see a paper by M. Johannsen et al.
1 M. Johannsen, U. Gneveckow, L. Eckelt et al., Int. J. Hyperthermia, 2005, 21(7), 637–647.
Sandhya Moise addressed Ivan Parkin and Kerry Chester: During magnetic
hyperthermia, the temperature rise is very local and falls with distance from the
nanoparticle surface. Is bulk temperature measurement of nanoparticle suspen-
sions accurate and representative of temperature changes encountered by the
cells?
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Kerry Chester replied: Yes it is true that bulk measurements may not be the
best comparison to in vivo or in vitromeasurements, however depending upon the
local concentration of nanoparticles within a cellular structure we have observed
similar experimental bulk temperature rises in vitro and in vivo. In these cases all
we can realistically say is that the temperature local to the cells has reached its
equilibrium point. Constructing an experiment to measure nanoparticle
temperatures would be very diﬃcult and at best would have to be modelled/
simulated.
Ivan Parkin responded: The local heating is one of the key reasons that
hyperthermia works. The bulk temperature measurement will greatly underesti-
mate the actual temperature at the surface of the nanoparticle. However it is a
guide to indicate heating and a measure of relative eﬀectiveness.
Stefan Borsley asked Nguyen TK Thanh: You are using imine formation with a
short, exible di-aldehyde (gluteraldehyde, GA) to bind to amine coated nano-
particles. This equilibrium process generally favours the carbonyl/amine side in
water, as imine formation results in liberation of water. Imine formation is acid
catalysed, so the pH of the solution will also inuence the rate of the reaction. Bi-
dentate binding of the GA to two amine ligands on the same nanoparticle also
must be considered, this might be expected to be a favourable process due to the
exibility and proximity of the unbound end of the GA, essentially resulting in a
higher eﬀective molarity.
Given these concerns, do you have any evidence for determining the number of
proteins bound per nanoparticle?
Stefan Borsley communicated: Further to this, the reversible nature of imine
formation means that, once bound, proteins may be released as the environ-
mental conditions change, favouring the equilibrium towards the aldehyde/
amine side, a particular concern when diluting the samples. Have you veried
that you do not get release of proteins from your protein-nanoparticle conjugates?
Nguyen T. K. Thanh communicated in reply: We used an excess of glutaral-
dehyde in the conjugation step. The imine hydrolysis is assisted through the
use of an acid catalyst. Under our conditions, the nal products
IONP@CHI@GA@PrA@antibody were formed, so evidently they were bound to
the bacteria selectively. We tested our conjugates aer three months and they
were still stable.
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